(Q36058647)

11 August 2017

1 reference

title

New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus (English)

1 reference

11 August 2017

0 references

0 references

1 reference

1

John S Oxford

1 reference

11 August 2017

4

Andrew Catchpole

1 reference

11 August 2017

2

Shobana Balasingam

1 reference

11 August 2017

Charlotte Chan

3

1 reference

11 August 2017

Robert Lambkin

series ordinal

5

1 reference

11 August 2017

publication date

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

16

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

13-21

1 reference

The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Hepatitis C virus replicons: potential role for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Animal origins of SARS coronavirus: possible links with the international trade in small carnivores

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Structural genomics of the SARS coronavirus: cloning, expression, crystallization and preliminary crystallographic study of the Nsp9 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

RNA virus error catastrophe: direct molecular test by using ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Virus detectives seek source of SARS in China's wild animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Infectious diseases. U.S. monkeypox outbreak traced to Wisconsin pet dealer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

The international response to the outbreak of SARS in 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Viral evolution and the emergence of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Aminopeptidase N inhibitors and SARS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

The Genome sequence of the SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Virology: SARS virus infection of cats and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Possible role of an animal vector in the SARS outbreak at Amoy Gardens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

WHO confirms SARS in Chinese journalist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

SARS: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Human infection with influenza H9N2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Confronting SARS: a view from Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Development of a standard treatment protocol for severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

21 January 2018

SARS: pharmacotherapy

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

CULTIVATION OF A NOVEL TYPE OF COMMON-COLD VIRUS IN ORGAN CULTURES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Identification of a new human coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

mRNA cap-1 methyltransferase in the SARS genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Are we ready for pandemic influenza?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

Virus-encoded proteinases and proteolytic processing in the Nidovirales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600102

10.1177/095632020501600102

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference